Spectrum Pharmaceuticals Announces Enrollment of First Group of Patients in Phase 1 Clinical Trial of RenaZorb® – Seekingalpha.com

May 29, 2012 Posted By: Leave a comment
--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (SPPI), a biotechnology company with fully integrated ... the information contained in this press release except as required by law. SPECTRUM PHARMACEUTICALS, INC.®, ZEVALIN®, FUSILEV®, and RenaZorb® are ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>